Influenza A Pseudoviruses

Easy and Ready-to-Use Pseudoviruses Advancing Influenza Research

Get your pseudovirus

Our Influenza pseudovirus catalog

Developed using third-generation lentiviral vectors, these pseudoviruses present the Influenza virus glycoprotein.
Browse through our Influenza A pseudoviruses library.

H5N1 pseudovirus

See details

H7N9 pseudovirus

See details

H3N2 pseudovirus

See details 

×

Get your document

Fill out the form below to get your document

"*" indicates required fields

Name*

First Last

Email*

This field is hidden when viewing the form

Document URL

Advantages

Our pseudoviruses are highly validated and come in various sizes to better adapt to your needs and increase your analysis reproducibility.

Sensitive and Easy Detection

Achieve a 10³ RLU signal-to-background ratio with just 1 µL

Support High-Throughput Screening

Various sizes available: 100 µL, 1 mL, 5 mL, 10 mL or more

Consistent results

Batch-to-batch quality and functional validation (infection, and neutralization)

Enable Specific Detection

Expression of hemagglutinin as the sole surface antigen

Enhanced safety

Use of a 3rd-generation lentivirus system for BSL-2 compatibility

Standard neutralizing antibody available

Flexible reporter system

Luciferase by default, GFP on demand

Order Now

Why using Influenza A Pseudovirus

Influenza Pseudotyped Viral Particles provide a safe, ready-to-use alternative to live influenza virus for neutralization and infectivity assays. These non-replicating particles mimic live virus structure, including strain-specific hemagglutinin (HA), while being safe to use in BSL-2 labs, even for highly pathogenic strains.

Unlike live viruses, they offer antigenic stability, eliminating concerns about genetic drift. Each pseudovirus carries a reporter gene (luciferase or GFP), enabling fast, quantifiable readouts with standard lab equipment.

This solution reduces time spent on virus culture, training, and QC, accelerating your research and data generation.

Applications

Pseudoviruses provide a safe and versatile platform for influenza virus research and the development of therapeutic countermeasures. Influenza pseudoviruses have several important applications in research and development, including:

Neutralizing Antibody Screening

Pseudoviruses enable rapid and safe screening of monoclonal antibodies targeting specific epitopes of the influenza virus.

Vaccine and Antiviral Drug Development

They are used to test the efficacy of new vaccines and antiviral drugs by evaluating their ability to induce neutralizing immune responses without the need for live pathogenic viruses.

Antiviral Resistance Studies

They help study viral mutations and evaluate how these mutations affect sensitivity to antiviral treatments.

Fundamental Research on Viral Entry

Pseudoviruses are used to understand the mechanisms of viral entry into host cells, which is crucial for developing new therapies targeting these processes.

Long-Term Immunity Across Subpopulations

Pseudoviruses are used to assess long-term innate and acquired (following vaccination or infection) immunity across different subpopulations

Order Now

Documentations

Quality Control Reports

See all QR reports

SDS

H5N1 pseudovirus
H7N9 pseudovirus
H3N2 pseudovirus

×

Get your document

Fill out the form below to get your document

"*" indicates required fields

Name*

First Last

Email*

This field is hidden when viewing the form

Document URL